首页 | 本学科首页   官方微博 | 高级检索  
     

免疫受损与非免疫受损患者下呼吸道铜绿假单细胞菌感染的临床对比
引用本文:邵长周,瞿介明,何礼贤,倪才妹,胡必杰. 免疫受损与非免疫受损患者下呼吸道铜绿假单细胞菌感染的临床对比[J]. 复旦学报(医学版), 2003, 30(6): 537-541,545
作者姓名:邵长周  瞿介明  何礼贤  倪才妹  胡必杰
作者单位:复旦大学附属中山医院肺科,上海,200032;复旦大学附属中山医院肺科,上海,200032;复旦大学附属中山医院肺科,上海,200032;复旦大学附属中山医院肺科,上海,200032;复旦大学附属中山医院肺科,上海,200032
基金项目:上海市卫生系统优秀学科梯队带头人培养计划“百人计划”(98BR030)资助项目
摘    要:目的 对比研究药物所致免疫受损宿主(immunocompromised host,ICH)与非免疫受损宿主(non-immunocompromised host,Non-ICH)下呼吸道铜绿假单胞菌(pseudomonas aeruginosa,PA)感染的临床表现、特点和耐药性。方法 总结5年内发生PA下呼吸道感染病例的药物所致ICH 106例和Non-ICH227例,对自下呼吸道标本分离出的1421株PA(ICH519株,Non-ICH 902株)的体外药敏活性进行统计分析。结果 ICH下呼吸道感染的PA标本来自气管镜检查较多(33.96%:14.98%),侵袭性操作多,临床较多表现为咳嗽、咳痰(82.08%:66.52%)和胸水(58.49%:32.60%),X线表现明显(64.05%:36.56%),多合并其他病原体感染(60.37%:40.09%),细菌耐药率高,患者死亡率高(33.96%:20.26%)。药敏试验:PA的抗生素耐药率依次为头哌酮街巴坦2.0%、哌拉西林/三唑巴坦3.8%、阿米卡星5.3%、头孢吡肟10.0%、头孢他啶11.3%、替卡西林/克拉维酸12.1%、亚胺培能12.9%等。ICH中多数抗生素如亚胺培能(27.1%:4.7%)、哌拉西林/三唑巴坦(7.4%:1.6%)和头孢哌酮/舒巴坦(3.2%:1.2%)耐药率高,2000年后药物敏感性下降。结论 ICH基础疾病重,易感因素多,合并下呼吸道PA感染时临床表现和抗生素耐药率不同于Non-ICH,临床防治中应重视。

关 键 词:免疫受损宿主  铜绿假单胞菌  耐药性  下呼吸道感染

A Comparative Study on the Clinical Manifestations of ICHs and Non-ICHs with Low Respiratory Tract Infections of Pseudomonas Aeruginosa
SHAO Chang-zhou,QU Jie-ming,HE Li-xian,NI Cai-mei,HU Bi-jie. A Comparative Study on the Clinical Manifestations of ICHs and Non-ICHs with Low Respiratory Tract Infections of Pseudomonas Aeruginosa[J]. Fudan University Journal of Medical Sciences, 2003, 30(6): 537-541,545
Authors:SHAO Chang-zhou  QU Jie-ming  HE Li-xian  NI Cai-mei  HU Bi-jie
Abstract:Purpose To study comparatively the antimicrobial susceptibility patterns and clinical manifes-tations of immuncocmpromised hosts (ICHs) resulting from immunosuppressive agents and non-immuno-compromised hosts (Non-ICHs) infected with pseudomonas aeruginosa(PA) in low respiratory tact in order to assist the rational clinical prevention and treatment of PA eruginosa infection. Methods Three hon-dred and thirty-three patients infected pseudomonas eruginosa including 106 ICHs and 227 Non-ICHs were included in this restrospective study. The clinical features and laboratory data of these patients were ana-lyzed. Meanwhile, we in vestigated the antimicrobial susceptibility pattems of 1 421 PA aeruginosa strains (519 from ICHs and 902 from Non-ICHs) in different years. Results Compared with Non-ICHs, ICHs had more risk factors, invasive treatments,other pathogens infections (60.37% ,40.09 % ) and more positive specimens coming from fibrobronchoscope (33.96 % , 14.96 % ), mainly from aspiration and bronchoalveolar lavage. Patients in two groups had different clinical presentations,especially in radiological findings,leural ef-fusions (58.49% in ICHs and 32.60% in Non-ICHs) ,cough and expectoration (82.08% in ICHs and 66. 52% in Non-ICHs). A high resistance rate of PA aeruginosa to common antibiotics was found in tow groups. Antimicrobial resistance was as follow: cefoperazone/sulbactam 2. 0%, piperacillin/tazobactam 3.8%,amikacin 5.3%,cefepime 10.0% % ,ceftazidime 11.3%,ticarcillin/clavulanicacid 12.1% ,imipenem 12.9% ,piperacillin 14.5% ,cefoperazone 15.6% . In these five years,the susceptibility of PA aeruginosa to most antibiotics was lower in ICHs than that in Non-ICHs. They became lower after the year 200. The prog-nosis was poorer in ICHs than that in Non-ICHs. Conclusions Compared with Non-ICHs, ICHs with low respiratory tract infections of PA had more risk factors and different clinical manifestations. The resis-tance rates of PA to different antibiotics were different.
Keywords:immunocompromised host  pseudomonas aeruginosa  drug resistance  low respiratory tract infection
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号